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Abstract
Different cross-sectional imaging techniques can be used
as a diagnostic tool for the evaluation of inﬂammatory
bowel disease (IBD). In this report the diagnostic per-
formances of ultrasonography, magnetic resonance
imaging and computed tomography in the detection of
IBD and the evaluation of known IBD are described,
together with a short update on patient preparation and
imaging technique of the respective modalities discussed.
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Introduction
Chronic inﬂammatory bowel disease (IBD) consists of
two main subtypes, i.e., Crohns disease (CD) and
ulcerative colitis (UC). During the last decades, the
incidence of CD has continued to increase worldwide,
reaching incidence rates ranging from 3.1 to 14.6/100,000
in North America and from 0.7 to 9.8/100,000 in Europe
[1]. Incidence rates of UC differ greatly between studies
and regions, varying from 1.5 to 24.5 per 100,000 person-
years [1, 2].
Crohns disease can be localized in any part of the
gastrointestinal tract, although the location of predilec-
tion is the terminal ileum, involvement of the terminal
ileum is observed in 90% of the patients with small-
intestinal CD, who in turn constitute 30–40% of all CD
patients. In 40–55% of the patients both ileum and colon
are affected, while in a minority (15–25%) only a colonic
localization is observed.
The earliest change caused by CD occurs in the mu-
cosa and submucosa and consists of hyperemia and
edema. Tiny aphthoid or superﬁcial ulcerations can be
seen when disease progresses. In more severe disease, the
disease extends transmurally with sometimes serosal
involvement. In this stage, mucosal ulcerations merge to
form deep longitudinal and transverse ulcerations while
bowel wall thickening and narrowing of the bowel lumen
can be observed due to signiﬁcant mucosal edema and
associated bowel spasms. In long-standing disease,
chronic obstruction can develop due to scarring, luminal
narrowing, and stricture formation. Extramural mani-
festations of CD are ﬁstulas, abscesses, adhesions,
creeping fat, and enlargement of lymph nodes.
Ulcerative colitis exclusively affects the colon with a
predictable way of spreading from distal to proximal in a
continuous manner; the rectum is often involved, but
rectal sparing can be observed. In previous cases, small
superﬁcial erosions can be seen, whereas in more severe
disease these ulcerations can be quite large. However,
only in very severe disease they penetrate the muscularis
layer. The mucosa is thickened because of round-cell
inﬁltration in the lamina propria. In chronic UC, a
marked hypertrophy of muscularis mucosae can be seen,
causing contraction, shortening, and narrowing of the
involved colon. The submucosa becomes thickened be-
cause of the deposition of fat or, in acute or subacute
cases, edema [3, 4].
Diagnostic modalities
The gold standard examination for the small bowel tra-
ditionally has been small bowel barium examination Correspondence to: Karin Horsthuis; email: k.horsthuis@amc.uva.nl
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using small-bowel follow-through [5, 6]. SBE is invasive
and burdensome, and requires an extensive bowel prep-
aration (dietary restrictions, use of laxatives). Moreover,
in the young population of CD patients, the ionizing
radiation required for SBE limits the use of this tech-
nique for follow-up of disease.
The advent of video capsule endoscopy (VCE) and
double-balloon endoscopy (DBE) has increased the
diagnostic possibilities. For VCE a capsule is swallowed
after a fasting period of up to 12 h and is propelled
through the bowel by peristalsis. Thus, the mucosal
surface of the small bowel can be depicted in detail
(Fig. 1). However, with VCE there is no facility to in-
crease visibility by insufflation of air or by tissue rinsing.
Moreover, tissue sampling and therapeutic interventions
are not possible. The use of VCE is contraindicated in
patients with (suspicion of) obstruction due to the risk of
capsule retention.
For DBE, a high-resolution video-endoscope with a
ﬂexible overtube is used. By alternately inﬂating and
deﬂating two balloons attached to the overtube and
endoscope the small bowel is threaded on the overtube.
Both an oral and an anal approach are possible; for the
oral approach no speciﬁc preparation is required, al-
though patients are asked to fast for at least 6 h before
the procedure. If the anal approach is used, bowel
cleansing such as is employed for traditional colonos-
copy is used. By using both the anal and oral approach,
DBE allows visualization of the entire small bowel, with
the possibility of obtaining tissue for analysis and the
added advantage of the possibility of endoscopic therapy
(e.g. dilatation of a stricture, cauterization of a bleeding
site). For DBE conscious sedation is a necessity.
Traditionally, ileocolonoscopy (CS) with tissue
sampling is considered to be the most valuable tool for
diagnosis and follow-up of disease in the colon and
terminal ileum [5, 7]. As UC solely affects the mucosa of
the colon, CS would suffice for diagnosis of disease and
evaluation of disease activity and extent. However,
when strictures are present as a complication of disease,
these might hamper execution of a complete examina-
tion, while in severe attacks of UC CS is relatively
contra-indicated due to the increased risk of bleeding or
perforation. For ileocolonic localizations of CD CS
would suffice as well, although inspection of the termi-
nal ileum is reported to fail in up to 27.8% of examin-
ations [8, 9].
Cross-sectional imaging modalities
The trans- and extramural extent of IBD cannot be
visualized with any of the abovementioned techniques.
Much research has been directed toward the potential of
cross-sectional imaging modalities for the diagnosis and
evaluation of IBD as with these techniques the bowel
lumen, the bowel wall and the extra-intestinal abdomen
including the visceral fat, the lymph nodes and the vas-
cular structures feeding and draining the bowel can be
visualized. An added advantage of these techniques is the
fact that they are limitedly to non-invasive.
Ultrasonography (US), computed tomography (CT)
and magnetic resonance imaging (MRI) are often used
for the evaluation of the abdomen. While in the USA the
technique of choice is CT, in Europe the focus is more on
MRI and US. This inclination is reﬂected by the majority
of CT studies on IBD patients originating from the USA,
while the majority of published studies on MRI and US
has been conducted in Europe.
Ultrasonography
Patient preparation and US technique. Patients are usu-
ally asked to fast for several hours before the scan to
diminish peristaltic movements and the amount of in-
traluminal air; in the available literature the minimum
fasting time described is 4 h, whereas overnight fasting is
also sometimes employed. Usually, no additional dietary
or cleansing measures are taken. Due to the limited pa-
tient preparation necessary and the non-invasive nature
of this examination, US can be considered to be a rela-
tively patient-friendly and straightforward examination.
Ultrasonography is mostly performed without the use
of enteral contrast medium. In two recent studies, the
effect of enteral contrast medium for diagnosis of IBD of
the small bowel was investigated; higher sensitivity val-
ues were obtained when enteral contrast medium had
been administered [10, 11]. In both studies the additional
value of enteral contrast medium permitted detection
of jejunal lesions that had escaped detection with
Fig. 1. VCE image of a 14-year-old male patient with known
CD. VCE was performed as small-bowel disease was sus-
pected. Image shows severe inflammation of the small bowel
with a stenosis.
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trast medium also increased accuracy [12, 13].
High-frequency transducers are preferred, such as
7.5 MHz [13–16].
The use of Doppler-US might provide helpful addi-
tional information on IBD, particularly on the degree of
disease activity. Using Doppler-US the vascularity of the
bowel wall can be assessed according to the intensity of
color signals and/or by the analysis of Doppler curves
(measurement of resistive index) obtained from vessels
detected within the bowel wall. Measurement of ﬂow
parameters of the superior and inferior mesenteric
arteries can also be performed.
Imaging criteria. The criterion that is most extensively
used for the diagnosis of CD is bowel wall thickening. In
most studies, the bowel wall is considered to be thickened
when thickness exceeds 3 mm (Fig. 2). In a meta-analysis
conducted by Fraquelli et al. [17] concerning US in CD
the respective diagnostic accuracies of different cut-off
values were compared; sensitivity for diagnosis of CD
decreased using a cut-off value of 4 mm instead of 3 mm
(from 88% to 75%), but specificity increased slightly
(from 93% to 97%). Other features that are considered
characteristic of CD on US are the presence of a stiff
bowel wall, modification or disappearance of bowel wall
stratification, presence of deep ulcers (seen as interrup-
tion of the submucosal hyperechoic rim by a hypoechoic
tract), a reduction of peristalsis and loss of haustration in
the colon. Extramural findings are fibrofatty prolifera-
tion, enlarged lymph nodes, and/or the presence of an
abscess or fistula.
Bowel wall thickening is considered to be a charac-
teristic feature of UC as well. Mural stratiﬁcation is
preserved in most UC patients due to the superﬁcial
pattern of inﬂammation. This feature can be used to
differentiate between CD and UC, although this was not
regarded sufﬁcient for differentiation in all studies on
this topic [12, 13]. In long-standing UC a tubular
appearance of the colon and loss of haustration can be
seen.
Diagnostic accuracy of US. Most studies regarding
diagnostic accuracy of US for diagnosis and follow-up of
IBD have been conducted in the last decade. Although
reported sensitivity and speciﬁcity values are high, with
the state-of-the-art equipment diagnostic accuracy could
possibly be higher than that previously reported.
In the hands of an experienced radiologist, US can be
very accurate for the detection of IBD. Reported sensi-
tivity values of US for the detection of IBD in patients
with suspected disease vary from 76% to 92% [15, 18, 19];
specificity values are also high. In patients with proven
IBD, reported sensitivity values for US are higher,
probably reflecting a higher index of suspicion [10, 20].
Reported segmental sensitivity values are lower; these are
below 78%, even if gray-scale US is combined with power
Doppler [21, 22]. Regarding the detection of extramural
complications, fistulas and abscesses can be identified
accurately on US [23, 24] (Fig. 3).
Although many US studies have been carried out,
most concerned either CD patients or both CD and UC
patients, and reported accuracy values are usually
applicable for both subgroups of disease. Although in the
study by Limberg and Osswald [13] separate accuracy
values are provided for US and CD, it is not clear from
these data if accuracy values were obtained from post
hoc separation of data. To our knowledge, as of yet no
prospective study has been performed with predeter-
mined imaging parameters to differentiate between CD
and UC.
Although US can be used for the assessment of both
small bowel and colon, disease localized in the duode-
num and jejunum is often missed [18, 19, 25]. Moreover,
the rectum and distal sigmoid cannot be visualized
accurately due to their pelvic location. This makes US
less suitable for the assessment of UC.
Doppler US has been proved useful in assessing
whether IBD is in an active phase or in remission; sig-
niﬁcant correlations were found between Doppler
parameters and disease activity, both in UC [26] and in
CD [27]. However, the only distinction made was be-
tween active and inactive disease, meaning no conclu-
sions can be drawn about the severity of active disease
from these data. As of yet, there is no standardized scale
to determine the degree of disease activity on US, neither
for CD nor for UC.
The spatial resolution of US is not high enough to
permit the detection of superﬁcial pathology, making this
modality less suitable for the diagnosis of early diseases
when compared with SBE. Although SBE can reportedly
be highly accurate when performed by skilled radiolo-
gists [28, 29], compared with VCE or DBE its sensitivity
Fig. 2. A 14-year female patient with known CD and inter-
mittent abdominal pain. US image shows the thickened wall of
the terminal ileum (arrowheads) with some infiltration of the
perivisceral fat.
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VCE and/or DBE might be very interesting in order to
determine the accuracy of US for small lesions and
accuracy for bowel segments that are difficult to access.
To our knowledge, no comparative studies have been
performed as of yet.
Computed tomography
Patient preparation. Patients are usually asked to fast for
several hours before the scan to diminish peristaltic
movements [31–33]. In addition, in some institutions a
bowel-cleansing regimen is applied, as a rule consisting
of mild laxatives. Dietary restrictions are also often
applicable. Although with this bowel preparation resid-
ual feces are usually present to some degree, the mural
presentation of disease enables the identification of dis-
ease even if the bowel wall is partly obscured.
There is consensus as to the indispensability of
enteral contrast medium for an abdominal CT exami-
nation for IBD. The contrast medium of choice should
be neutral (meaning an attenuation value comparable
with water), as a neutral contrast medium allows opti-
mal distinction between bowel wall and lumen. While in
some institutions enteral contrast medium is adminis-
tered orally (CT enterography), in other institutions
controlled distention is achieved by inﬂow of contrast
medium through a nasojejunal catheter (CT-enterocly-
sis). Although by some authors CT-enteroclysis is
propagated as the controlled infusion provides a more
consistent distention of the small bowel than CT-ente-
rography, especially of the jejunum [34], others report
that with the right choice of contrast medium and
correct timing of intake excellent distention of all small
bowel loops can be obtained after the oral administra-
tion of contrast medium [31, 33]. In only one small
study, CT enteroclysis and CT enterography were
compared, but both the degree of luminal distention
and the diagnostic accuracy did not show significant
differences [35].
Imaging technique. Technical developments have allowed
the widespread use of multi-slice scanners. With these
scanners volumes can be scanned in a very short breath
hold, allowing the acquisition of isotropic voxels for
multiplanar reformatting. Thin slices should be used to
permit the detection of subtle pathology.
Before CT enterography sometimes metoclopramide
is given to increase gastric emptying and peristaltic
movements of the small bowel [31]. The use of antiperi-
staltic drugs is not standard. In a recently published
update on CT enteroclysis, Rajesh and Maglinte [32]
report that in their institution all patients undergoing CT
enteroclysis receive conscious sedation. Although this
most probably decreases patient discomfort to a large
degree, this can considerably increase the in-hospital time
for patients as they will have to stay in a recovery unit
after the procedure until the anesthetic effects have worn
off.
Intravenous contrast medium should be administered
for a comprehensive CT examination of the bowel. In a
recent study, the optimal timing of scanning after the
administration of intravenous contrast medium was
determined; Schindera et al. [36] found that peak mural
enhancement of normal small-bowel wall occurs on
average about 50 s after contrast administration or 14 s
after peak aortic enhancement.
Imaging criteria. The main feature considered indicative
of both CD and UC is bowel wall thickening. Whereas in
earlier studies cut-off values for pathological bowel wall
thickening have varied between 2.5 mm and 10 mm, in
recent publications of experts in the ﬁeld bowel wall
thickness exceeding 3 mm is described as pathological
[31, 33] (Fig. 4). Mural thickening is not seen in early
superficial disease, precluding CT from being a first-line
examination for (suspicion of) superficial disease.
Increased bowel wall enhancement after the admin-
istration of intravenous contrast medium is also consid-
ered as an indicative of active disease [37–39]. Whereas in
Fig. 3. A 25-year-old female patient with
known CD of the terminal ileum. A US image
shows a large abscess (arrowheads) that was
located ventrally and cranially of the bladder.
B US image shows a fistula (arrowheads) that
originated from the abscess.
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ment was between pathological enhancement (i.e., hyper-
enhancement) and normally enhancing bowel walls, in a
recent publication the degree of mural enhancement was
found to correlate with disease activity [38].
Bowel wall enhancement can be transmural, but also
layered. This layered enhancement pattern, which is
represented by a thickened intestinal wall with a middle
layer of low attenuation surrounded on each side by
layers of higher attenuation, has been termed the target
sign; this is due to the presence of edema or the deposi-
tion of fat in the submucosa.
Diagnostic accuracy of CT. The accuracy of CT has
mainly been investigated for small-bowel disease. In
suspected CD sensitivity was 83% when compared with
SBE [40]. When compared with ileoscopy sensitivity
values vary from 80% to 88% [34, 35, 41]. Segmental
sensitivity of CT was somewhat lower (71.8%) in a study
by Molnar et al. [42], comparing CT with SBE and CS.
Superﬁcial lesions (such as aphthoid lesions) are not
accurately visualized on CT, making CT less suitable as a
ﬁrst-line examination for the suspicion of mild disease.
This was already evident from studies comparing CT
with CS and/or SBE, but in a recent meta-analysis
comparing CT with VCE was shown that the yield of CT
compared with the yield of CE was 30% vs. 69% [43]. No
comparative studies have been published regarding CT
vs. DBE.
Extramural complications are well shown on CT, al-
though the lower contrast resolution of CT makes this
modality less suitable for the detection of ﬁstulas and
abscesses than MRI in patients with CD [44] (Fig. 5). In
a recent study, the relationship between increased
attenuation of perivisceral fat and disease activity was
determined; one of the most specific markers of active
disease was increased attenuation in the perivisceral fat
[37].
Hardly any studies have focused on the accuracy of
CT colonography for the detection of ileocolonic IBD.
This is possibly partly due to the fact that for the rectal
administration of contrast medium the rectum is ob-
scured by the rectal catheter, precluding diagnosis of
rectal IBD, speciﬁcally UC. It does seem clear that CTC
is unable to detect ulcerative lesions; even diffuse
inﬂammation with large ulcerations can be missed. CTC
might however be useful in patients with colonic stenosis
or narrowing [45, 46].
Magnetic resonance imaging
Patient preparation. While in some studies on MRI a
period of several hours of fasting was deemed sufﬁcient,
in others full bowel cleansing was performed, as the
reference standard, (i.e., CS) was performed on the same
day. There is no consensus yet as to what constitutes the
optimal bowel preparation for MRI. However, as a
limited bowel preparation does not seem to negatively
affect accuracy, it might be sufﬁcient to limit the bowel
preparation to a fasting period taking into account the
patient-friendliness of the respective preparations.
Luminal distention by means of use of enteral con-
trast medium is indispensable for an adequate evaluation
of the bowel as collapsed bowel can hide or mimic dis-
ease. As was the case with CT, for MRI of the small
bowel contrast medium is either administrated by mouth
or by enteroclysis. An advantage of MR enteroclysis over
MR enterography is the fact that it allows ﬂuoroscopic
monitoring of the inﬂow of contrast medium and thereby
provides functional information on bowel distensibility.
An advantage of MR enterography is the fact that it can
be considered more patient-friendly and also that no
ionizing radiation is necessary. To our knowledge, only
one study has been carried out in which both methods of
contrast medium administration were compared. In this
study by Schreyer et al. [47] all patients (n = 21)
underwent both MRI enterography and MRI enteroc-
lysis; no difference in accuracy compared with SBE was
noted by the investigators (Fig. 6).
Whereas for MR enteroclysis mostly a methylcellu-
lose suspension is used, for MR enterography many
different contrast media have been tested. The main
subdivision is between positive, negative, and biphasic
contrast media. A biphasic contrast medium performs
best for the identiﬁcation of pathology on both T2-and
T1-weighted sequences as adequate delineation between
hypointense bowel wall and hyperintense lumen is seen
on T2-weighted sequences while on T1-weighted images
the enhancing bowel wall can be easily discriminated
from the hypointense lumen. An artiﬁcial sugar-solution
Fig. 4. A 60-year old female patient who underwent CT
enterography for suspected bowel obstruction. Just 1 month
earlier at ileocolonoscopy CD of the terminal ileum was dis-
covered; the terminal ileum was not intubated because of the
stenosis. Axial image shows the severely thickened bowel
wall of the ileum (arrowheads) with only a pinpoint bowel
lumen remaining.
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distention of small bowel loops with negligible side ef-
fects [48, 49].
Imaging technique. Mostly, both T2-weighted and T1-
weighted sequences are used for the MRI evaluation of
the bowel. On T2-weighted images the bowel wall can be
appreciated and bowel wall stratiﬁcation—if pres-
ent—can be well apprehended. As feces can show bright
signal intensity on T1-weighted sequences, it is important
to perform a pre-contrast T1-weighted sequence in order
to be able to determine whether high signal intensity was
already present before intravenous contrast administra-
tion, indicating the presence of stool.
Another sequence that is propagated by many au-
thors is the TrueFISp sequence, a sequence that is
insensitive to motion and breathing artifacts. This se-
quence, that makes use of a T2/T1 ratio, adequately
delineates the bowel wall and the mesentery, allowing
adequate assessment of disease (Fig. 7). When combin-
ing a T2-weighted sequence or TrueFISP sequence and a
T1-weighted sequence, a comprehensive MRI examina-
tion can be carried out in less than 30 min.
Imaging criteria. A bowel wall thickness exceeding 3 mm
should be considered as an indicative of disease. Besides
bowel wall thickening the most important criterion
indicative of active IBD is pathological bowel wall
enhancement after the administration of intravenous
gadolinium. Bowel wall enhancement can always be seen
as the bowel is a highly vascularized structure. However,
in active IBD increased enhancement can be observed,
due to the increased vascularization and the increased
capillary leakage of the affected tissue (Fig. 8). In CD it
has been hypothesized that the degree of enhancement
correlates with the degree of disease severity, but this
statement has not been extensively corroborated [50–53].
Bowel wall stratiﬁcation can be observed on T2-
weighted images as a bright line within the two dark
stripes of the mucosal and muscularis propria layers,
likely related to the presence of fat or edema in the
submucosal layer. On fat-suppressed T2-weighted images
Fig. 5. A 25-year-old female
patient with known CD of the
terminal ileum (same patient as
pictured in Fig. 3). A CT-scan
was performed to determine
involvement of the small bowel.
A Coronal image shows the
abscess (arrowheads). B Axial
image again shows the
abscess again (arrowheads). C
Coronal image shows the
fistula (arrowhead).
Fig. 6. A A 38-year-old female with
complaints of vomiting and an iron-deficiency
anemia who was suspected of CD and
underwent MRI-enteroclysis to evaluate the
small bowel. Coronal TrueFISP image shows
good distention of jejunal bowel loops after
controlled infusion of contrast medium. B A
12-year-old male patient with known CD who
underwent MR enterography for the
evaluation of the small bowel. Coronal
TrueFISP image shows good distention of
jejunal bowel loops after oral administration of
contrast medium.
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as a persistent bright signal suggests the presence of
edema, whereas complete suppression of the submucosal
signal suggests fat inﬁltration and quiescent disease [54].
Extramural manifestations of disease that can be
identiﬁed on MRI are ﬁstulas, abscesses, ﬁbrofatty pro-
liferation, and enlarged lymph nodes.
Diagnostic accuracy. The accuracy of MRI of the small
bowel has been extensively investigated. In many Euro-
pean institutions, conventional enteroclysis is increas-
ingly being replaced by MRI enteroclysis or MRI
enterography as MRI has proved to be highly accurate in
both the detection of disease in patients with known IBD
as in patients in whom IBD of the small bowel was
suspected [52, 55, 56]. However, the studies that have
been performed were mostly small and concerned se-
lected populations with either a high suspicion of disease
or known CD of the small bowel. Larger studies
including the full spectrum of disease activity should be
conducted.
As was the case with CT and US, MRI is not suitable
for the detection of superﬁcial disease due to the limited
spatial resolution. This ﬁnding is corroborated by a study
comparing MRI and VCE in patients with CD [57].
Significantly more inflammatory lesions were detected
with VCE in the jejunum and partly in the ileum of pa-
tients with CD. However, these findings had no effect on
the therapeutic approach of the individual patients. The
accuracy of MRI has not been compared with DBE as of
yet.
As mentioned before, MRI can be used for the eval-
uation of extramural disease. Due to the high contrast
resolution abscesses are very conspicuous on T1-weighed
fat suppressed images after the administration of intra-
venous Gadolinium. MRI is also very sensitive for the
detection of ﬁstulas [47, 52, 58] (Fig. 9).
In recent years, the accuracy of MRI for the detection
of ileocolonic IBD has been investigated by means of
MRI colonography. After administration of rectal con-
trast medium the colon (and sometimes the terminal
ileum) was assessed for disease. Conﬂicting results were
reported: while in one study high accuracy values were
reported [59], in others segmental sensitivity values were
around 32% [60, 61].
Regarding the accuracy of MRI in differentiation
between CD and UC conﬂicting results have been re-
Fig. 7. A 18-year-old female patient with
known CD. MRI-enterography was performed
for suspicion of active CD of the neoterminal
ileum. A Coronal TrueFISp image shows
enlarged mesenteric lymph nodes
(arrowheads). B Coronal TrueFISP image
shows thickened bowel wall of the
neoterminal ileum (arrowheads).
Fig. 8. A 12-year-old male patient with known CD who
underwent MR-enterography for the evaluation of the small
bowel (same patient depicted in Fig. 6b). Axial T1-weighted
image shows pathological enhancement of thickened small-
bowel loops after administration of intravenous contrast
medium (arrowheads). Approximately, 1 m of small bowel
(terminal jejunum, proximal ileum) was shown to be affected.
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location of inﬂammatory changes, the degree of
involvement, the continuity or discontinuity of disease,
and the presence of complications it was possible to
differentiate between CD and UC [51, 62], others report
a limited value in differentiation of disease [63].
Theoretically, a whole-bowel examination would be
possible with MRI, by the administration of contrast
medium orally and rectally. This has been attempted [64,
65] and was deemed feasible. More research is needed to
establish the diagnostic value of this combined approach.
At the moment, MRI colonography does not seem to be
able to replace CS.
Discussion
Compared with conventional imaging methods, CT, US,
and MRI are accurate methods for the detection of IBD
of the small bowel, both in patients suspected of disease
as in patients with known IBD. Although subtle lesions
cannot be depicted with any of these modalities, clini-
cally more relevant ﬁndings can be accurately depicted.
Therefore, cross-sectional imaging should be incorpo-
rated in a comprehensive clinical evaluation of suspected
IBD and for follow-up of CD. The exact role cross-sec-
tional imaging techniques can play for follow-up in UC
should be more extensively studied.
As US is easily accessible, widely available, and
inexpensive, it is recommended to use abdominal US as
ﬁrst-line modality in patients with suspected IBD of the
small bowel. MR enterography would be a good alter-
native, especially as the assessment of the degree of dis-
ease activity can be better performed on MRI than on
US. Although CT enterography is a very accurate tech-
nique and is used in many institutions, its role in IBD is
limited by the ionizing radiation needed, especially due to
the repetitive use for follow-up in often young individ-
uals. If possible, it might be advisable to reserve this
technique for patients in whom imaging is needed at very
short notice as CT enterography can be performed very
fast and is readily available.
Although VCE has shown to be more accurate in
depicting subtle lesions in the small bowel than MRI or
CT, its role should be limited as of yet as the true beneﬁt
of VCE is not clear yet. As there are presently no stan-
dardized criteria for the diagnosis of CD with VCE,
deﬁnitions with regard to what constitutes a positive
ﬁnding might differ between studies. Moreover, the
clinical signiﬁcance of ﬁnding a single mucosal break or a
few superﬁcial aphthous lesions is not clear yet. Also,
speciﬁcity and positive predictive values for VCE have
not been established. At this time, it might be good to
reserve VCE as a second-line modality if cross-sectional
imaging has not shown abnormalities but the suspicion
of disease remains standing despite these negative ﬁnd-
ings.
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